Arcus Biosciences Depreciation & Amortization 2011-2026 | RCUS

Annual Depreciation & Amortization Arcus Biosciences

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
10 M	10 M	8 M	6 M	4 M	3 M	3.58 M	3.66 M	2.61 M	1.31 M	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
10 M	1.31 M	5.22 M

Quarterly Depreciation & Amortization Arcus Biosciences

2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	3 M	-	-	-	3 M	-	-	-	2 M	-	4.52 M	-	1 M	-	2.58 M	-	800 K	-	2.37 M	1.63 M	842 K	-	800 K	800 K	953 K	-	900 K	900 K	800 K	-	700 K	600 K	500 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
4.52 M	500 K	1.51 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Amphastar Pharmaceuticals AMPH	31.6 M	$ 19.68	0.92 %	$ 920 M	USA
Amarin Corporation plc AMRN	3.02 M	$ 14.5	0.03 %	$ 6.02 B	Irlanda
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Autolus Therapeutics plc AUTL	7.55 M	$ 1.39	1.46 %	$ 355 M	Britain
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	63 K	-	10.36 %	$ 9.8 M	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Heron Therapeutics HRTX	2.31 M	$ 0.81	3.74 %	$ 135 M	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Benitec Biopharma BNTC	66 K	$ 11.05	0.64 %	$ 455 M	USA
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands
Calithera Biosciences CALA	300 K	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	259 K	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.14 M	-	-	$ 3.74 B	USA
Immunovant IMVT	377 K	$ 24.1	4.85 %	$ 3.65 B	USA
Incyte Corporation INCY	93.3 M	$ 90.36	-0.47 %	$ 17.6 B	USA
InMed Pharmaceuticals INM	202 K	$ 0.74	-9.75 %	$ 1.81 M	Canada
Clovis Oncology CLVS	8.5 M	-	-7.23 %	$ 13 M	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Compugen Ltd. CGEN	461 K	$ 2.13	1.91 %	$ 199 M	Israel
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	1.4 M	$ 4.43	4.6 %	$ 735 M	Canada
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA